Medication possession and glycemic control among uninsured type 2 diabetics

Journal for Nurse Practitioners

Volumn 8, Issue 7, 2012, Pages 528-533

  Ward, Wesley ^a   Armbrecht, Eric S ^b   Lavin, Mary A ^b  

^a Conway Interfaith Clinic ^*  (United States)

^b SAINT LOUIS UNIVERSITY   (United States)

Author keywords

Glycemic control; Medication possession; Type 2 diabetes uninsured

Indexed keywords

EID: 84863745005     PISSN: 15554155     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nurpra.2012.02.001     Document Type: Article

References (18)

1. Centers for Disease Control and Prevention 2011 National Diabetes Fact Sheet Accessed May 15, 2012. http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf.
2. Cooke CE, Lee HY, Tong YP, Haines ST Persistence with injectable antidiabetic agents in members with type 2 diabetes in a commercial managed care organization. Curr Med Res Opin 2010, 26(1):231-238.
3. Phillis-Tsimikas A, Zhang Q, Walker C Glycemic control with insulin glargine as part of an ethnically diverse, community-based diabetes management program. Am J Ther 2006, 13:466-472.
4. Centers for Disease Control and Prevention 2005 National Diabetes Fact Sheet Accessed May 15, 2012. http://www.cdc.gov/diabetes/pubs/factsheet05.htm.
5. Centers for Disease Control and Prevention 2007 National Diabetes Fact Sheet Accessed May 15, 2012. http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2007.pdf.
6. Putzer GJ, Ramirez AM, Sneed K, et al. Prevalence of patients with type 2 diabetes mellitus reaching the American Diabetes Association's target guidelines in a university primary care setting. South Med J 2004, 97(2):145-148.
7. Benoit SR, Fleming R, Philis-Tsimikas A, Ji M Predictors of glycemic control among patients with type 2 diabetes: a longitudinal study. BMC Public Health 2005, 5:36.
8. Piette JD, Heisler M, Wagner TH Problems paying out-of-pocket medication cost among older adults with diabetes. Diabetes Care 2004, 27(2):384-391.
9. Ruelas V, Goldman D, Roybal MG, Lu Y, Peters A Clinical and behavioral correlates of achieving and maintaining glycemic targets in an underserved population with type 2 diabetes. Diabetes Care 2009, 23:54-56.
10. Chuma J, Abuya T, Memusi D, et al. Reviewing the literature on access to prompt and effective malaria treatment in Kenya: implications for meeting the Abuja targets. Malar J 2009, 8:243.
11. Kim N, Agostini JA, Justice AC Refill adherence to oral hypoglycemic agents and glycemic control in veterans. Ann Pharmacother 2010, 44:800-808.
12. Kindmalm L, Melander A, Nilsson JL Refill adherence of antihyperglycaemic drugs related to glucose control (HbA1c) in patients with type 2 diabetes. Acta Diabetol 2007, 44(4):209-213.
13. Anderson JE, Bardsley J, Buse JB, et al. Standards of medical care in diabetes 2010 Accessed May 15, 2012. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797382/.
14. Krapek K, King K, Warren SS, et al. Medication adherence and associated hemoglobin A1c in type 2 diabetes. Ann Pharmacother 2004, 38:1357-1362.
15. Rhee MK, Slocum W, Ziemer DC, et al. Patient adherence improves glycemic control. Diabetes Educator 2005, 31(2):240-250.
16. Best JH, Lavillotti K, Deyoung MB, Garrison LP The effects of exenatide BID on metabolic control, medication use, and hospitalization in patients with type 2 diabetes mellitus in clinical practice: a systematic review. Diabetes Obes Metab 2011, 14(5):387-398.
17. Iltz JL, Baker DE, Setter SM, Keith Campbell R Exenatide: an incretin mimetic for the treatment of type 2 diabetes mellitus. Clin Ther 2006, 28(5):652-665.
18. Aschengrau A, Seage GR Essentials of Epidemiology in Public Health 2008, Jones and Bartlett Publishers, Sudbury, MA. 2nd ed.